(Q39780472)

14 September 2017

In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae (English)

1 reference

14 September 2017

0 references

1 reference

Dhople AM

1

1 reference

14 September 2017

Ibanez MA

series ordinal

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

39

1 reference

14 September 2017

9

1 reference

14 September 2017

2116-2119

1 reference

Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

Autoradiographic and metabolic studies of Mycobacterium leprae

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

In Vitro Growth of Mycobacterium lepraemurium , an Obligate Intracellular Microbe

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162891

The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae

15 June 2018

1 reference

12 December 2020

Limited in vitro multiplication of Mycobacterium leprae

1 reference

12 December 2020

Activity of ofloxacin against Mycobacterium leprae in the mouse

1 reference

12 December 2020

Recent advances in the chemotherapy of leprosy

1 reference

12 December 2020

In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae

1 reference

12 December 2020

Therapeutic efficacy of some new quinolones and a combination of ofloxacin with rifampin against Mycobacterium leprae infection induced in athymic nude mice

1 reference

12 December 2020

In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice

1 reference

12 December 2020

Elimination of leprosy as a public health problem

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.39.9.2116

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

8540726

1 reference